Prophylactic phenobarbital and whole-body cooling for neonatal hypoxic-ischemic encephalopathy.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 20553847.
- Also identified by DOI 10.1016/j.jpeds.2010.04.005.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In infants with hypoxic-ischemic encephalopathy, cooling reduces death/neurodevelopmental impairment, whereas prophylactic anticonvulsants may not. This retrospective analysis shows no reduction in neurodevelopmental impairment (23% in prophylactic phenobarbital group vs 45% in controls, P = .3) but fewer clinical seizures in cooled infants who received prophylactic phenobarbital (15% vs 82% P < .0001).
Medical subject headings
- Excitatory Amino Acid Antagonists
- Hypoxia-Ischemia, Brain
- Phenobarbital